Inflammation and Type 2 Diabetes: Results from KORA Augsburg
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is associated with a systemic low-grade inflammation. First data provided by cross-sectional studies from as early as the 1960s demonstrated elevated systemic levels of glycoproteins and acute-phase reactants and increased leukocyte counts in type 2 diabetes patients. Subsequently, prospective studies showed that elevated concentrations of several acute-phase proteins and cytokines are predictive of later type 2 diabetes. Immune gene variants in man and in animal models were found to affect insulin resistance and diabetes incidence. Antidiabetic treatment by medication, diet or physical activity results in a significant decrease of systemic immune mediator concentrations. Immunological analyses of the KORA Survey S4 (1999/2001) allowed us to show that levels of circulating acute-phase proteins like CRP and of IL-6 are highly correlated and associated not only with overt type 2 diabetes, but already with impaired glucose tolerance (IGT) pointing out a role of these mediators in the pathogenesis of type 2 diabetes. On the contrary, TNFalpha was neither coregulated with CRP nor associated with diabetes status. Our study therefore shows that type 2 diabetes is accompanied by a non-random and differential upregulation of components of the innate immunity and suggests that this inflammatory condition is involved in the aetiology of the disease. Future work will extend the range of analysed immune mediators to chemokines and will also investigate the association of immune markers with indices of obesity to elucidate the relevance of this traditional risk factor for low-grade inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated circulating concentrations of inflammatory biomarkers are consistently found in people with T2DM. 5,6”
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Recent studies indicated that obesity is associated with an increasing infiltration of macrophages into adipose tissue [39–41].”
BackgroundXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738 · cited 1×
“Importantly, inflammation must be considered as an intricate network of stimuli, humoral and cellular proinflammatory responses, counterregulatory mechanisms and active suppression of inflammation in the absence of stimuli that do not require a potent reaction [24].”
BackgroundBaggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,192 · cited 1×
“Chemokines represent a family of small molecular weight proteins which control leukocyte trafficking and activation and act as key mediators of inflammation and other patho-physiological states [37, 38].”
BackgroundDiabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?
(1962) · PubMed Central · Cited by 2,182
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Pickup, J. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.813 · Cited by 1,414 · cited 2×
“These studies described the association of type 2 diabetes and elevated levels of acute-phase proteins like C-reactive protein (CRP), cytokines like interleukin-6 (IL-6) and other markers of leukocyte or endothelial cell activation [9 and references therein, 10].”
BackgroundGerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357 · cited 1×
“Chemokines represent a family of small molecular weight proteins which control leukocyte trafficking and activation and act as key mediators of inflammation and other patho-physiological states [37, 38].”
BackgroundPickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,242
Adiponectin and protection against type 2 diabetes mellitus
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120 · cited 1×
“…a single marker has been described as yet which appears to be protective: The adipocyte-derived cytokine adiponectin combines insulin-sensitising and anti-inflammatory properties, and high levels of serum adiponectin are associated with significantly reduced risk of diabetes development [12, 13].”
BackgroundAdiponectin and development of type 2 diabetes in the Pima Indian population
Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094 · cited 1×
“…a single marker has been described as yet which appears to be protective: The adipocyte-derived cytokine adiponectin combines insulin-sensitising and anti-inflammatory properties, and high levels of serum adiponectin are associated with significantly reduced risk of diabetes development [12, 13].”
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
“(5) There is a need for toxicological evaluation of wellcharacterised AGE in animal studies.”
InfluentialSelf-citationKORA - A Research Platform for Population Based Health Research
Holle, R., Happich, M., Löwel, H., & Wichmann, H. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858235 · Cited by 754
Self-citationFirmann, M., Mayor, V., Vidal, P. M., Bochud, M., Pécoud, A., Hayoz, D., Paccaud, F., Preisig, M., Song, K. S., Yuan, X., et al. (2008) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-8-6 · Cited by 721
Akash, M. S. H., Rehman, K., & Liaqat, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26174 · Cited by 690
Metadata
- Authors
- Herder, C., Illig, T., Rathmann, W., Martin, S., Haastert, B., Müller-Scholze, S., Holle, R., Thorand, B., Koenig, W., Wichmann, H., & Kolb, H.
- Affiliations
- Deutsches Diabetes-Zentrum e.V. (DE)
- Helmholtz Munich (DE)
- Venue
- Das Gesundheitswesen
- Publisher
- Georg Thieme Verlag KG
- Published
- 2005-07-20
- Volume
- 67
- Issue
- S 01
- Pages
- 115-121
- ISSN
- 0941-3790 (ISSN-L)
- 1439-4421
- OpenAlex
- W2074266524
- Cited by
- 97
- References
- 42
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 1 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 5 · 2015: 5 · 2014: 3 · 2013: 5 · 2012: 1
- FWCI
- 2.61
- Type
- journal article
- Language
- de
- Open access
- bronze
- doi.org
- Locations
- Das Gesundheitswesen (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, low-grade inflammation, acute phase proteins, C-reactive protein, interleukin-6, TNF-α, impaired glucose tolerance, insulin resistance, innate immunity, cytokines, diabetes pathogenesis, obesity
- MeSH terms
- Acute-Phase Proteins, Adult, Aged, Diabetes Mellitus, Type 2, Female, Germany, Humans, Inflammation, Male, Middle Aged, Population Surveillance, Registries, Research Design, Risk Factors, Cohort Studies, Biomarkers, Comorbidity, Incidence, Survival Analysis, Case-Control Studies, Cytokines, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammation and Type 2 Diabetes: Results from KORA Augsburg. https://app.cochat.ai/papers/10.1055/s-2005-858252
- The paper
- Herder, C., Illig, T., Rathmann, W., Martin, S., Haastert, B., Müller-Scholze, S., Holle, R., Thorand, B., Koenig, W., Wichmann, H., & Kolb, H. (2005). Inflammation and Type 2 Diabetes: Results from KORA Augsburg. Das Gesundheitswesen. https://doi.org/10.1055/s-2005-858252
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.